Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CBL |
Variant | R420Q |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | CBL R420Q lies within the RING domain of the Cbl protein (PMID: 17446348). R420Q results in impaired internalization, ubiquitination, and degradation of Egfr and decreased inhibition of Erk1/2 phosphorylation (PMID: 25178484), and disrupts Cbl ubiquitin ligase activity, leading to activation of Flt3 signaling, and is transforming in cell culture in the presence of Flt3 (PMID: 17446348). |
Associated Drug Resistance | |
Category Variants Paths |
CBL mutant CBL exon9 CBL R420Q CBL mutant CBL inact mut CBL R420Q |
Transcript | NM_005188.4 |
gDNA | chr11:g.119278541G>A |
cDNA | c.1259G>A |
Protein | p.R420Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |